Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3293-3297

  Sheu, Shiow Yunn ^a,b   Chiang, Hsüch Ching ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anthracene (anthrarobin); Anthraquinone (purpurin); Antibacterial; Xanthine oxidase inhibitors

Indexed keywords

ALIZARIN; ALLOPURINOL; ALOE EMODIN; ANTHRAFLAVIC ACID; ANTHRAQUINONE DERIVATIVE; DANTRON; EMODIN; HYPOXANTHINE; PURPURIN; QUINALIZARIN; QUINIZARIN; RHEIN; SHIKIMIC ACID; SHIKONIN; URIC ACID; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANTHRAQUINONES; ENZYME INHIBITORS; KINETICS; LECTINS; MUTAGENS; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINE OXIDASE;

EID: 0030730650     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Chang WS, Lee YJ, Lu FJ and Chiang HC: Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 13: 2165-2170, 1993.
2. Chang WS, Chang YH, Lu FJ and Chiang HC: Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res 14: 501-506, 1994.
3. Chang WS, Wen PC and Chiang HC: Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Res 15: 703-708, 1995.
4. Chang WS and Chiang HC: Structure-activity relationship of coumarins in xanthine oxidase inhibition. Anticancer Res 15: 1969-1974, 1995.
5. Chang WS, Yan GF and Chiang HC: Inhibitory effects of phenolic carboxylic acid analogues on xanthine oxidase. Anticancer Res 15: 2097-2100, 1995.
6. Chiang HC, Lo YJ and Lu FJ: Xanthine oxidase inhibitors from the leaves of Alsophila spinulosa (Hook) Tryon. J Enzyme Inhibi 8(1): 61-71, 1994.
7. Sheu SY and Chiang HC: Inhibitory effects of plant growth regulators on xanthine oxidase. Anticancer Res 16: 311-315, 1996.
8. Sheu SY, Lin YC and Chiang HC: Inhibition of xanhtine oxidase by cytokinins and related substances. Anticancer Res 16: 3571-3576, 1996.
9. Chinese Drug Dictionary, New edition, Vol 1, p.113, Fig.0197, Vol 3, p.2012, Fig.3871 and p.2501, Fig.4829; Sin Wen Hong Publications Inc. Taipei, Taiwan, 1985.
10. Chinese Drug Dictionary, New edition, Vol 1, p.113, Fig.0197, Vol 3, p.2012, Fig.3871 and p.2501, Fig.4829; Sin Wen Hong Publications Inc. Taipei, Taiwan, 1985.
11. Chinese Drug Dictionary, New edition, Vol 1, p.113, Fig.0197, Vol 3, p.2012, Fig.3871 and p.2501, Fig.4829; Sin Wen Hong Publications Inc. Taipei, Taiwan, 1985.
12. Nishioka I: Chemistry of Rhubarb constituents, p.40-49, ROC-Japan Symposium on Oriental Medicine, Nov. 6-7, 1987.
13. Kökoglu E, Belce A, Özyurt E and Tepeler Z: Xanthine oxidase levels in human brain tumours. Cancer Lett 50: 179-181, 1990.
14. Feigelson P and Davidson J: The in vitro inhibition of xanthine dehydrogenase by 8-azaguanine. Cancer Res 16: 352-356, 1956.
15. Bennett LL Jr. and Allan PW: Metabolism and metabolic effects of 8-azainosine and 8-azaadenosine. Cancer Res 36: 3917-3923, 1976.
16. Skipper HE, Robins RK anf Thomson RJ: Inhibition of experimental neoplasms by 4-aminopyrazolo[3,4-d]pyrimidine. Proc Soc Exp Biol and Med 89: 594, 1955.
17. Woolley DW and Shaw EJ: Some imidazo-1,2,3-triazines and their biological relationship to the purines. J Biol Chem 189: 401, 1951.
18. Al-Khalidi UAS and Geha RS: The sensitivity of serum xanthine oxidae and serum glutamic pyruvic transaminase in detecting liver damage. Clin Chim Acta 14: 833-835, 1966.
19. Shamma'A MH, Nasrallah S, Chaglassian T, Kachadurian AK and Al-khalidi UAS: Serum xanthine oxidase: A sensitive test of acute liver injury. Gastroenterology 48: 226-230, 1965.
20. Smith HJ: Design of enzyme inhibitors as drugs. In: Xanthine oxidase inhibitors (Sandler M and Smith HJ eds). Oxford, Oxford University Press, 1989, pp. 770-779.
21. Colowick SP and Kaplan NO: Methods in Enzymology. Vol. 74. Immunochemical Techniques. Part C edited by Langone JJ and Vanakis HV. In: (Halfman CJ ed), Section II. Data analysis. Chapter 32. Concentrations of binding proteins and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays. Pp. 481-497, and (Ukraincik K and Piknosh W eds), Chapter 33, Microprocessor-based radioimmunoassay data analysis. New York; Academic Press Inc 1981, pp.497-508.
22. Lineweaver H and Burk D: The determination of enzyme dissociation constants. J Am Chem Soc 56: 658-666, 1934.
23. nd ed. In Chapter 4. Enzyme. Enzyme inhibition, p. 250, competitive inhibition; p. 260, uncompetitive inhibition; p. 261, mixed type inhibition. New York, John Wiley and Sons, 1976.
24. Huang SS, Yeh SF and Hong CY: Effect of anthraquinone derivatives on lipid peroxidation in rat heart mitochondria: Structure-activity relationship. J Natural Prod 58(9): 1365-1371, 1995.
25. Brinkworth RI and Fairlie DP: Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase. Biochim Biophys Acta 1253 (1): 5-8, 1995.
26. Chinese Drug Dictionary. New edition. Vol 2, p.1589, Fig. 3059. Sin Wen Hong Publications Inc. Taipei, Taiwan, 1985.
27. Itokawa H: Research on antineoplastic drugs from natural sources. Especially from higher plant. Yakugaku Zassi 108 (9): 824-841, 1988.
28. Chinese Drug Dictionary. New edition. Vol 1, p.113-119, Fig. 0197. Sin Wen Hong Publications Inc. Taipei, Taiwan, 1985.
29. Brown JP and Brown RJ: Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat Res 40(3): 203-224, 1976.